Skip to main content
. 2015 Feb 1;8(2):1154–1164.

Figure 5.

Figure 5

A and B. 50 μM Neogrifolin treatment for 24 h induced activation of caspase-9, caspase-3, and cleavage of PARP in osteosarcoma cells. z-VAD-fmk, a universal inhibitor of caspases, prevented caspase-3 activation and PARP cleavage. C. Cell growth inhibition induced by neogrifolin was abolished by z-VAD-fmk preincubation in osteosarcoma cells.